Funding for this research was provided by:
Received: 24 September 2020
Accepted: 2 October 2020
First Online: 16 December 2020
Ethics approval and consent to participate
: Informed consent was gained for the patient to form the subject of this case report in line with CARE guidance. No special ethics approval was necessary for this case report.
: The patient gave consent for their clinical details along with any identifying images to be published in this study.
: Dr. Nashat has received a personal travel grant from Actelion Pharmaceuticals UK. Dr. Constantine has received a personal educational grant from Actelion Pharmaceuticals UK. Dr. Dimopoulos has received nonfinancial support from Actelion Pharmaceuticals; and has been a consultant to and received grants and personal fees from Actelion Pharmaceuticals, Pfizer, GlaxoSmithKline, and Bayer/MSD. Dr. Barracano has no competing interests to disclose.